The FDA said on Wednesday that it is investigating reports of blood cancers -- including life-threatening cases of ...

Applied Therapeutics said on Wednesday that the U.S. FDA declined to approve its drug to treat galactosemia, a rare genetic ...

The U.S. Food and Drug Administration is weighing the need for a regulatory action on bluebird bio's gene therapy for a rare ...

The co-leader of President-elect Donald Trump’s initiative to cut government spending has a financial stake in the biotech ...

The seafood salad may be of particular risk to those customers who have an allergy or severe sensitivity to soy, the FDA has ...

Outlook Therapeutics’ eye disease drug has failed to match Roche’s Lucentis in a key trial. The biotech brushed off the ...

President-elect Donald Trump’s Friday night news dump of health care nominees included the expected naming of Dr. Marty ...

“Phenylephrine is an oral decongestant and vasoconstrictor,” Valley Health Pharmacist Dr. Aaron Stone. “By that, it means it ...

In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight ...

The US FDA concludes 30-day review of Paradigm Biopharmaceuticals' phase III trial protocol for new knee osteoarthritis ...

Singulair, a popular asthma medication, could be linked to severe side effects, including suicide, a study from the FDA found ...

Americans who cannot afford Wegovy or have struggled to find it have been turning to often-cheaper compounded versions sold ...